SAMR registration update

NZX Code: ATM
ASX Code: A2M

The a2 Milk Company Limited
www.thea2milkcompany.com


12 September 2022
NZX/ASX Market Release

SAMR registration update
The a2 Milk Company (a2MC, the Company) notes the announcement from Synlait Milk (Synlait) today providing
an update on the State Administration for Market Regulation (SAMR) renewal and registration processes for
a2MC’s China label infant milk formula (IMF) product, 至初®, which is produced by Synlait.
Renewal of existing GB registration
As noted in the Company’s FY22 results announcement on 29 August 2022, a2MC’s current China label IMF
product registration was due to expire in late September 2022. As anticipated, Synlait has received notification
from SAMR that the current registration has been renewed. In effect, this will allow Synlait to manufacture
a2MC’s current registered China label product until 21 February 2023 when transition to the new GB standard is
required. Product manufactured up until this date is allowed to be sold in market after that date.
New GB registration process
a2MC and Synlait are also working closely together in relation to the registration of a2MC’s China label IMF
products, formulated in line with China’s new GB standards. While this is also progressing, timing is uncertain and
remains subject to SAMR approval.
It is noted that the Ministry for Primary Industries (MPI) has co-operation arrangements in place with SAMR
which, amongst other things, positions New Zealand well in relation to China registration processes.

The a2 Milk Company’s Managing Director and CEO, David Bortolussi said:
• “We are pleased that our current product registration has been renewed, effectively to late February
2023, and we will continue to work collaboratively with Synlait and SAMR in relation to registration of our
China label IMF product formulated in line with China’s new GB standards.
• “We remain focused on the China market and are looking forward to the opportunity to make our newly
formulated infant milk product available to parents and infants in China.
• “In all circumstances, The a2 Milk Company fully respects SAMR’s governance and timing of this important
registration process.”


Authorised for release by

David Bortolussi
Managing Director and Chief Executive Officer
The a2 Milk Company Limited

2


For further information, please contact:
Investors / Analysts
David Akers
Group Head of Investor Relations and Sustainability
M +61 412 944 577
david.akers@a2milk.com



Rebecca Culbertson
Investor Relations Manager
M +61 400 955 295
rebecca.culbertson@a2milk.com
Media
Rick Willis
M +61 411 839 344
rick@networkfour.com.au
Media – New Zealand
Barry Akers
M +64 21 571 234
akers@senescallakers.co.nz